Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amena Warner

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Allergy|February 4, 2021
EAACI Biologicals Guidelines-dupilumab for children and adults with moderate-to-severe atopic dermatitisIoana Agache, Cezmi A Akdis, Mubeccel Akdis, et al.
Allergy|July 29, 2021
EAACI Biologicals Guidelines-Omalizumab for the treatment of chronic spontaneous urticaria in adults and in the paediatric population 12-17 years oldIoana Agache, Cezmi A Akdis, Mubeccel Akdis, et al.
BMJ Open Quality|September 7, 2024
Factors influencing implementation and adoption of direct oral penicillin challenge for allergy delabelling: a qualitative evaluationYogini H Jani, Iestyn Williams, Mairead McErlean, et al.
The Journal of Infection|February 8, 2024
A multicentre observational study to investigate feasibility of a direct oral penicillin challenge in de-labelling 'low risk' patients with penicillin allergy by non-allergy healthcare professionals (SPACE study): Implications for healthcare systemsMamidipudi Thirumala Krishna, Rashmeet Bhogal, Bee Yean Ng, et al.
Current Biology : CB|March 12, 2021
Environmental DNA reveals links between abundance and composition of airborne grass pollen and respiratory healthFrancis M Rowney, Georgina L Brennan, Carsten A Skjøth, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|November 16, 2025
Identifying and Prioritising BSACI Service Standards for Paediatric Allergy in the United KingdomPaul J Turner, Elizabeth Angier, Karen Brunas, et al.
Health and Social Care Delivery Research|April 15, 2025
Direct oral penicillin challenge in secondary care with low-risk patients: the SPACE mixed-methods study with cost-effectiveness analysisMamidipudi Thirumala Krishna, Yogini H Jani, Iestyn Williams, et al.
The World Allergy Organization Journal|May 6, 2024
World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) guideline update - XII - Recommendations on milk formula supplements with and without probiotics for infants and toddlers with CMAAntonio Bognanni, Alessandro Fiocchi, Stefania Arasi, et al.
The World Allergy Organization Journal|May 11, 2022
World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guideline update - XIV - Recommendations on CMA immunotherapyJan L Brozek, Ramon T Firmino, Antonio Bognanni, et al.
The World Allergy Organization Journal|September 23, 2024
World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) guideline update - XI - Milk supplement/replacement formulas for infants and toddlers with CMA - Systematic reviewAntonio Bognanni, Ramon T Firmino, Stefania Arasi, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Allergy|February 4, 2021
EAACI Biologicals Guidelines-dupilumab for children and adults with moderate-to-severe atopic dermatitisIoana Agache, Cezmi A Akdis, Mubeccel Akdis, et al.
Allergy|July 29, 2021
EAACI Biologicals Guidelines-Omalizumab for the treatment of chronic spontaneous urticaria in adults and in the paediatric population 12-17 years oldIoana Agache, Cezmi A Akdis, Mubeccel Akdis, et al.
BMJ Open Quality|September 7, 2024
Factors influencing implementation and adoption of direct oral penicillin challenge for allergy delabelling: a qualitative evaluationYogini H Jani, Iestyn Williams, Mairead McErlean, et al.
The Journal of Infection|February 8, 2024
A multicentre observational study to investigate feasibility of a direct oral penicillin challenge in de-labelling 'low risk' patients with penicillin allergy by non-allergy healthcare professionals (SPACE study): Implications for healthcare systemsMamidipudi Thirumala Krishna, Rashmeet Bhogal, Bee Yean Ng, et al.
Current Biology : CB|March 12, 2021
Environmental DNA reveals links between abundance and composition of airborne grass pollen and respiratory healthFrancis M Rowney, Georgina L Brennan, Carsten A Skjøth, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|November 16, 2025
Identifying and Prioritising BSACI Service Standards for Paediatric Allergy in the United KingdomPaul J Turner, Elizabeth Angier, Karen Brunas, et al.
Health and Social Care Delivery Research|April 15, 2025
Direct oral penicillin challenge in secondary care with low-risk patients: the SPACE mixed-methods study with cost-effectiveness analysisMamidipudi Thirumala Krishna, Yogini H Jani, Iestyn Williams, et al.
The World Allergy Organization Journal|May 6, 2024
World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) guideline update - XII - Recommendations on milk formula supplements with and without probiotics for infants and toddlers with CMAAntonio Bognanni, Alessandro Fiocchi, Stefania Arasi, et al.
The World Allergy Organization Journal|May 11, 2022
World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guideline update - XIV - Recommendations on CMA immunotherapyJan L Brozek, Ramon T Firmino, Antonio Bognanni, et al.
The World Allergy Organization Journal|September 23, 2024
World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) guideline update - XI - Milk supplement/replacement formulas for infants and toddlers with CMA - Systematic reviewAntonio Bognanni, Ramon T Firmino, Stefania Arasi, et al.
Pageof 3